First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Hits New 52-Week Low – Here’s What Happened

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)’s share price hit a new 52-week low on Wednesday . The stock traded as low as $8.50 and last traded at $194.42, with a volume of 900 shares trading hands. The stock had previously closed at $190.10.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

The firm has a market cap of $1.19 billion, a PE ratio of 21.72 and a beta of 0.65. The business’s 50 day moving average price is $182.18 and its 200 day moving average price is $169.87.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Large investors have recently modified their holdings of the company. Holistic Financial Partners grew its position in First Trust NYSE Arca Biotechnology Index Fund by 135.4% during the 1st quarter. Holistic Financial Partners now owns 5,791 shares of the company’s stock worth $985,000 after purchasing an additional 3,331 shares during the last quarter. Cerity Partners LLC grew its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 14.8% during the first quarter. Cerity Partners LLC now owns 5,375 shares of the company’s stock worth $914,000 after buying an additional 694 shares in the last quarter. IFP Advisors Inc grew its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.9% in the first quarter. IFP Advisors Inc now owns 10,438 shares of the company’s stock valued at $1,776,000 after purchasing an additional 194 shares during the period. Kestra Private Wealth Services LLC lifted its position in First Trust NYSE Arca Biotechnology Index Fund by 3.2% during the first quarter. Kestra Private Wealth Services LLC now owns 8,724 shares of the company’s stock valued at $1,484,000 after buying an additional 268 shares in the last quarter. Finally, WMG Financial Advisors LLC lifted its position in First Trust NYSE Arca Biotechnology Index Fund by 6.0% during the first quarter. WMG Financial Advisors LLC now owns 3,305 shares of the company’s stock valued at $562,000 after buying an additional 186 shares in the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.